Cargando…
Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial
IMPORTANCE: Female gender is a major risk factor for dementia; however, gender has not yet been adequately addressed by clinical trials. A recent study demonstrated that sodium benzoate, a D-amino acid oxidase inhibitor, improved cognitive function in early-phase Alzheimer disease. OBJECTIVE: To exa...
Autores principales: | Lin, Chieh-Hsin, Chen, Ping-Kun, Wang, Shi-Heng, Lane, Hsien-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060832/ https://www.ncbi.nlm.nih.gov/pubmed/33881530 http://dx.doi.org/10.1001/jamanetworkopen.2021.6156 |
Ejemplares similares
-
Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
por: Lin, Chieh-Hsin, et al.
Publicado: (2020) -
The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019) -
Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2022) -
PM405. Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2016) -
NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer’s Disease
por: Huang, Yu-Jhen, et al.
Publicado: (2012)